## ASML: ASML Holding N.V. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -2.3% below STRENGTH zone (4.0-10.0%); PEG 1.99 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.3% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($994.06)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Morgan Stanley Sticks to Their Buy Rating for ASML Holding NV (0QB8)**
- Source: The Globe and Mail | 20251220T220940 | Bullish | Relevance: 100%
- Morgan Stanley analyst Lee Simpson has maintained a "Buy" rating on ASML Holding NV (0QB8) with a price target of €1,000.00. This follows similar "Buy" ratings from Goldman Sachs, despite Bernstein maintaining a "Hold" rating. ASML Holding NV reported strong third-quarter earnings with increased revenue and net profit compared to the previous year.

**2. ASML Holding N.V. Stock (NASDAQ: ASML) Outlook: Latest News, Analyst Forecasts, and Key Risks as of Dec. 20, 2025**
- Source: ts2.tech | 20251220T210936 | Neutral | Relevance: 100%
- This article details the latest news, analyst forecasts, and key risks for ASML Holding N.V. (NASDAQ: ASML) as of December 20, 2025. It examines how China's workarounds for chipmaking restrictions and geopolitical tensions are impacting ASML, alongside the bullish prospects of High-NA EUV lithography and strong industry forecasts. The report also touches on analyst ratings, potential stock splits, and future catalysts like the 2026 outlook update and share buyback programs.

**3. Morgan Stanley Sticks to Their Buy Rating for ASML Holding NV (0QB8)**
- Source: The Globe and Mail | 20251220T100833 | Bullish | Relevance: 100%
- Morgan Stanley analyst Lee Simpson has maintained a Buy rating on ASML Holding NV with a €1,000.00 price target. This comes as ASML Holding NV continues to show strong financial performance, reporting a quarterly revenue of €7.52 billion and net profit of €2.12 billion. Other firms like Goldman Sachs have also issued Buy ratings, while Bernstein maintained a Hold.

**4. Voya Investment Management LLC Grows Stock Holdings in ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251222T130940 | Somewhat-Bullish | Relevance: 100%
- Voya Investment Management LLC increased its stake in ASML Holding N.V. (NASDAQ:ASML) by 31.5% in the third quarter, now holding 28,775 shares valued at $27.86 million. The semiconductor company has received a "Moderate Buy" rating from analysts with an average target price of $1,171.83, despite concerns over potential Chinese reverse-engineering of its technology. ASML also recently announced an increased quarterly dividend of $1.857 per share.

**5. Flputnam Investment Management Co. Raises Position in ASML Holding N.V. $ASML**
- Source: MarketBeat | 20251222T090940 | Neutral | Relevance: 100%
- Flputnam Investment Management Co. significantly increased its stake in ASML Holding N.V. (NASDAQ:ASML) by 245.2% in the third quarter, now owning 7,115 shares valued at approximately $6.89 million. While ASML maintains a strong market position with a "Moderate Buy" consensus rating and positive customer adoption, increasing reports of Chinese efforts to reverse-engineer or upgrade older ASML tools pose a significant geopolitical and intellectual property risk to its future demand in China. The article also details other institutional investor activity, recent news impacting ASML, analyst recommendations, and the company's financial performance.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | B of A Securiti | $1331 | $1092 | +22% |
| 2025-12-01 | JP Morgan | $1275 | $1175 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | B of A Securiti | main | Buy |
| 2025-12-01 | JP Morgan | main | Overweight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 8.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 1.5% (+170.0%)
- Fisher Asset Managem: 1.1% (+2.5%)
- Capital World Invest: 1.1% (-4.1%)
- Capital Internationa: 1.0% (+17.3%)
- State Farm Mutual Au: 0.7% (0.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.3% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.99 elevated, pricing in significant growth expectations. Forward P/E 40.8x stretched relative to 5% growth. Quality metrics strong (ROE 54%, ROA 16%, margin 29%). Analyst sentiment positive (2 raises, avg +15%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $410.3B |
| Beta | 1.35 |
| 52W Range | $578.51 - $1141.72 |
| Short Interest | 0.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.99 |
| Forward P/E | 40.8 |
| Current P/E | 42.8 |
| YoY Growth | 4.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.0% to -2.3% (-3.3% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.3pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.27x) but short-term weakness (below SMA20). MACD histogram bearish (-8.56), momentum weakening. RSI neutral at 49. OFD pattern: -MLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.32% (CS: 23) | Weak |
| RSI_14 | 49.3 | Neutral |
| MACD Histogram | -8.56 | Bearish |
| vs SMA20 | 0.982x | Below |
| vs SMA50 | 1.010x | Above |
| vs SMA200 | 1.270x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1056.98
- **Stop Loss:** $994.06 (6.0% risk)
- **Target:** $1119.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 19
- **Position Value:** $20,082.62
- **Portfolio %:** 20.08%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-28 (Est: $7.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.37 | $5.49 | +2.1% |
| 2025Q2 | $5.25 | $5.90 | +12.4% |
| 2025Q1 | $5.79 | $6.00 | +3.7% |
| 2024Q4 | $6.73 | $6.84 | +1.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*